Global Diabetes Market Size, Industry Trends, Share and Forecast 2018-2023

Posted by nabeel on January 21st, 2021

The global diabetes market is expected to grow at a CAGR of 7.6% percent for the forecasted period of 2018-2023. The market is segmented on the basis of the type of diabetes, drugs class, and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 8.9%. Some of the top-selling diabetic drugs include Lantus (Sanofi), Januvia (Merck And Co), Humalog (Eli Lily And Co), Novorapid (Novo Nordisk), Levemir (Novo Nordisk), Victoza (Novo Nordisk), Janumet (Merck And Co.), Novolog (Novo Nordisk), Humalin (Eli Lily And Co.) And Galvus (Novartis). With the diabetic population expected to cross the 350 million market by 2030 the market is expected to show a strong growth rate. Diabetic drugs are highly priced which could be one of the major drawbacks.

Get Free Sample Copy @

https://www.omrglobal.com/request-sample/diabetes-market 

Diabetic devices include blood glucose meters and insulin delivery devices. The market for blood glucose meters will have the highest market share compared to the insulin delivery systems such as syringes and injection pens. Continuous glucose monitoring systems will have the highest market growth. Meter and strips are expected to dominate the overall market share in diabetic devices.

MARKET SEGMENTATION

DIABETES MARKET BY TYPE

• TYPE 1 DIABETES
• TYPE 2 DIABETES
• GESTATIONAL

DIABETES MARKET BY DRUG CLASS

• ALPHA-GLUCOSIDASE INHIBITORS
• AMYLIN ANALOGS
• ANTIDIABETIC COMBINATIONS
• DIPEPTIDYL PEPTIDASE 4 INHIBITORS
• INCRETIN MIMETICS
• INSULIN
• MEGLITINIDES
• NON-SULFONYLUREAS
• SGLT-2 INHIBITORS
• SULFONYLUREAS
• THIAZOLIDINEDIONE

DIABETES MARKET BY DEVICES

• BLOOD GLUCOSE METERS
• BLOOD GLUCOSE STRIPS
• INSULIN INJECTION PENS
• INSULIN SYRINGES
• CONTINUOUS GLUCOSE MONITORING SYSTEMS
• INSULIN PUMPS
• LANCETS

COMPETITIVE LANDSCAPE

• MARKET SHARE ANALYSIS
• KEY COMPANY ANALYSIS

REGIONAL ANALYSIS

NORTH AMERICA

• UNITED STATES
• CANADA
• REST OF NORTH AMERICA

EUROPE

• UNITED KINGDOM
• FRANCE
• GERMANY
• ITALY
• SPAIN
• REST OF EUROPE

ASIA PACIFIC

• INDIA
• CHINA
• JAPAN

REST OF THE WORLD

COMPANY PROFILES

• ABBOTT LABORATORIES INC
• ALERE INC.
• ASCENSIA DIABETES CARE
• ASTRAZENECA LTD
• BAYER AG
• BECTON, DICKINSON AND COMPANY
• BIOCON LTD.
• BOEHRINGER INGELHEIM
• BRISTOL-MYERS SQUIBB
• CELLNOVO GROUP
• DEXCOM INC
• DIAMYD MEDICAL
• ELI LILY AND CO.
• F. HOFFMANN-LA ROCHE LTD.
• GLAXOSMITHKLINE
• GLENMARK
• JOHNSON AND JOHNSON
• JOSLIN DIABETES CENTER
• LIFESCAN
• LUPIN PHARMACEUTICALS LTD
• MANNKIND CORPORATION
• MEDTRONIC PLC
• MERCK & CO.
• MICRO LABS LTD
• MSD PHARMACEUTICALS
• NOVARTIS
• NOVO-NORDISK
• PFIZER
• PROMETHEON PHARMA, LLC
• SANOFI
• SMITHS MEDICAL
• SUN PHARMACEUTICALS INDUSTRIES LTD
• TAKEDA PHARMACEUTICAL LTD.
• TANDEM DIABETES CARE
• THERMALIN, INC
• USV PRIVATE LIMITED

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/report-customization/diabetes-market 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com 
Contact no: +91 780-304-0404